3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with thromboplastin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsieh, KY; Wei, CK; Wu, CC | 1 |
1 other study(ies) available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and thromboplastin
Article | Year |
---|---|
YC-1 Prevents Tumor-Associated Tissue Factor Expression and Procoagulant Activity in Hypoxic Conditions by Inhibiting p38/NF-κB Signaling Pathway.
Topics: Blood Coagulation; Blood Platelets; Cell Line, Tumor; Cyclic Nucleotide-Regulated Protein Kinases; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Thromboplastin | 2019 |